Analysts Set Tempus AI, Inc. (NASDAQ:TEM) Target Price at $48.67

Tempus AI, Inc. (NASDAQ:TEM) has been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $54.22.

A number of research firms have weighed in on TEM. JPMorgan Chase & Co. upped their target price on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Piper Sandler reiterated a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Bank of America downgraded Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Loop Capital upped their target price on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Finally, Needham & Company LLC restated a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research note on Wednesday, August 7th.

Tempus AI Trading Down 7.5 %

TEM stock opened at $52.40 on Monday. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The stock’s 50 day moving average price is $51.25. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TEM. First Horizon Advisors Inc. bought a new position in Tempus AI in the 3rd quarter valued at approximately $30,000. Sandia Investment Management LP bought a new position in Tempus AI in the 2nd quarter valued at approximately $136,000. Vestor Capital LLC bought a new position in Tempus AI in the 3rd quarter valued at approximately $153,000. Stifel Financial Corp bought a new position in Tempus AI in the 3rd quarter valued at approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new position in Tempus AI in the 3rd quarter valued at approximately $258,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.